ZA897975B - Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1h-imidazol-4-yl)methyl)piperazine - Google Patents

Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1h-imidazol-4-yl)methyl)piperazine

Info

Publication number
ZA897975B
ZA897975B ZA897975A ZA897975A ZA897975B ZA 897975 B ZA897975 B ZA 897975B ZA 897975 A ZA897975 A ZA 897975A ZA 897975 A ZA897975 A ZA 897975A ZA 897975 B ZA897975 B ZA 897975B
Authority
ZA
South Africa
Prior art keywords
methyl
diphenylmethyl
imidazol
methylphenyl
salt
Prior art date
Application number
ZA897975A
Other languages
English (en)
Inventor
Alastair Brereton Selkirk
Brereton Selkirk Alastair
Michael John Dey
John Dey Michael
Original Assignee
Syntex Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Ltd filed Critical Syntex Pharma Ltd
Publication of ZA897975B publication Critical patent/ZA897975B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
ZA897975A 1988-10-21 1989-10-20 Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1h-imidazol-4-yl)methyl)piperazine ZA897975B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/260,628 US4973591A (en) 1988-10-21 1988-10-21 Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine

Publications (1)

Publication Number Publication Date
ZA897975B true ZA897975B (en) 1991-06-26

Family

ID=22989940

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897975A ZA897975B (en) 1988-10-21 1989-10-20 Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1h-imidazol-4-yl)methyl)piperazine

Country Status (14)

Country Link
US (1) US4973591A (xx)
EP (1) EP0365363B1 (xx)
JP (1) JPH02157224A (xx)
KR (1) KR900005962A (xx)
AT (1) ATE88094T1 (xx)
AU (1) AU636581B2 (xx)
CA (1) CA2001170A1 (xx)
DE (1) DE68905995T2 (xx)
DK (1) DK523389A (xx)
ES (1) ES2057145T3 (xx)
GR (1) GR3007663T3 (xx)
IE (1) IE63292B1 (xx)
NZ (1) NZ231094A (xx)
ZA (1) ZA897975B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK178590D0 (da) * 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
SE469717B (sv) * 1992-02-20 1993-08-30 Ingemar Naeslund Klaemma, speciellt foer tillslutning av paasar
JPH08511005A (ja) * 1993-06-01 1996-11-19 コーテックス ファーマシューティカルズ インコーポレイテッド 神経疾患の治療におけるアルカリ性または酸性ホスファターゼインヒビター
CA2545190A1 (en) * 2003-11-14 2005-05-26 Mochida Pharmaceutical Co., Ltd. Agent for preventing and treating language disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
GB1184714A (en) * 1965-12-16 1970-03-18 Science Union & Cie Di- and Tri-Phenylpropyl Piperazine Derivatives
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
DE1795314A1 (de) * 1968-09-11 1972-01-05 Merck Patent Gmbh N-(Thiazolyl-2)-piperazine
US3927011A (en) * 1973-05-10 1975-12-16 Yoshitomi Pharmaceutical 2-Aminoalkyl-1-(pyridylcarbonylphenyl)imidazole compounds
US4022783A (en) * 1975-10-29 1977-05-10 Usv Pharmaceutical Corporation Piperazinyl-imidazolines
GB1551993A (en) * 1976-09-21 1979-09-05 Malesci Sas Pharmacologiclly active derivatives of 1 alkyl 4-phenylpiperazines and the preparation thereof
IT1159698B (it) * 1978-05-29 1987-03-04 Rotta Research Lab Derivati 5-nitro-imidazolici della piperazina ad attivita' antiprotozoica
US4243806A (en) * 1979-06-13 1981-01-06 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
US4404382A (en) * 1980-09-17 1983-09-13 The Upjohn Company Piperazinyl-substituted imidazoles
HU187399B (en) * 1980-12-24 1985-12-28 Sumitomo Chemical Co Process for preparing imidazolyl-propanol derivatives
US4435399A (en) * 1981-07-18 1984-03-06 Pfizer Inc. 2-Aryl-1-(imidazol-1-yl)-8-(4-piperazin-1-ylphenoxy) octan-2-ol antifungal agents
US4829065A (en) * 1987-04-24 1989-05-09 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives

Also Published As

Publication number Publication date
ATE88094T1 (de) 1993-04-15
IE893382L (en) 1990-04-21
AU636581B2 (en) 1993-05-06
NZ231094A (en) 1991-12-23
EP0365363B1 (en) 1993-04-14
JPH02157224A (ja) 1990-06-18
DE68905995T2 (de) 1993-09-16
DK523389D0 (da) 1989-10-20
DK523389A (da) 1990-04-22
IE63292B1 (en) 1995-04-05
US4973591A (en) 1990-11-27
GR3007663T3 (xx) 1993-08-31
CA2001170A1 (en) 1990-04-21
ES2057145T3 (es) 1994-10-16
AU4356989A (en) 1990-04-26
EP0365363A1 (en) 1990-04-25
KR900005962A (ko) 1990-05-07
DE68905995D1 (de) 1993-05-19

Similar Documents

Publication Publication Date Title
Wang et al. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys
Greenstein Naltrexone: a clinical perspective.
KR910019630A (ko) 프라바스타틴 및 제약상 허용되는 담체로 이루어진 혈관형성수술후의 재협착 발생 방지용 제약 조성물
RU95119831A (ru) Рисперидонпамоат
US5716952A (en) Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists
NZ228576A (en) Piroxicam as its alkali or alkaline earth metal salt
ZA897975B (en) Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1h-imidazol-4-yl)methyl)piperazine
IL83086A0 (en) Stable,injectable solutions of vinca dimer salts
ATE97572T1 (de) Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe.
US5330978B1 (en) Phosphonic acid derivatives and use thereof
KR960034200A (ko) 항편두통성 인돌릴알킬-피리딘일 및 피리미딘일피페라진의 1,2,5-티아디아졸 유도체
ATE233105T1 (de) Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid
JO1195B1 (en) Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension
KR880004810A (ko) 소화성 궤양 치료제
KR890012961A (ko) N-(저급알킬)-2-(3'-우레이도벤질)피롤리딘
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
KR900701263A (ko) 이보파민의 수용성 산 부가 염을 포함하는 안과용 약학 조성물
Gordon et al. Preclinical ocular irritation findings with dorzolamide hydrochloride
EP0229963A3 (en) 4-thienyl-dihydropyridines, process for their preparation and their use as pharmaceutical preparations
MX9603766A (es) Metodos de administracion de benzamidas n-substituidas o fenotiazinas.
DK0421707T3 (da) Forbedringer i behandlingen af ufrugtbarhed
JPS56115722A (en) Analgesic